MedTrace Logo

Restore Myocardial Function With CorMatrix® ECM® Particulate (P-ECM)

NCT02139189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2017-07-19

No results posted yet for this study

Summary

The purpose of this CorMatrix P-ECM safety and feasibility study is to evaluate the safety and functional effect of the CorMatrix P-ECM.

Conditions

Interventions

DEVICE

P-ECM Implant

P-ECM Implant into damaged ischemic and/or infarcted myocardium

Sponsors & Collaborators

  • CorMatrix Cardiovascular, Inc.

    lead INDUSTRY

Principal Investigators

  • Piotr Suwalski, Professor · Central Clinical Hospital of the Ministry of Interior in Warsaw

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02139189 on ClinicalTrials.gov